170 related articles for article (PubMed ID: 14514772)
1. Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection.
Kerr JR; McCoy M; Burke B; Mattey DL; Pravica V; Hutchinson IV
J Clin Pathol; 2003 Oct; 56(10):725-7. PubMed ID: 14514772
[TBL] [Abstract][Full Text] [Related]
2. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.
Kerr JR; Cunniffe VS; Kelleher P; Coats AJ; Mattey DL
J Med Virol; 2004 Sep; 74(1):147-55. PubMed ID: 15258981
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue.
Kerr JR; Barah F; Mattey DL; Laing I; Hopkins SJ; Hutchinson IV; Tyrrell DAJ
J Gen Virol; 2001 Dec; 82(Pt 12):3011-3019. PubMed ID: 11714978
[TBL] [Abstract][Full Text] [Related]
4. Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines.
Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Josephson AS; Durkin HG; Smith-Norowitz TA
Clin Immunol; 2003 Aug; 108(2):152-8. PubMed ID: 12921761
[TBL] [Abstract][Full Text] [Related]
5. Cytokine responses in acute and persistent human parvovirus B19 infection.
Isa A; Lundqvist A; Lindblom A; Tolfvenstam T; Broliden K
Clin Exp Immunol; 2007 Mar; 147(3):419-25. PubMed ID: 17302890
[TBL] [Abstract][Full Text] [Related]
6. IgE, CD8(+)CD60+ T cells and IFN-alpha in human immunity to parvovirus B19 in selective IgA deficiency.
Bluth MH; Norowitz KB; Chice S; Shah VN; Nowakowski M; Durkin HG; Smith-Norowitz TA
Hum Immunol; 2005 Oct; 66(10):1029-38. PubMed ID: 16386644
[TBL] [Abstract][Full Text] [Related]
7. Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients.
Naciute M; Mieliauskaite D; Rugiene R; Maciunaite G; Mauricas M; Murovska M; Girkontaite I
Cytokine; 2017 Aug; 96():41-48. PubMed ID: 28288327
[TBL] [Abstract][Full Text] [Related]
8. Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful.
Searle K; Schalasta G; Enders G
J Med Virol; 1998 Nov; 56(3):192-8. PubMed ID: 9783684
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection.
Kerr JR; Cunniffe VS
Rheumatology (Oxford); 2000 Aug; 39(8):903-8. PubMed ID: 10952747
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
Jones LP; Erdman DD; Anderson LJ
J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) T-cell responses against the VP1-unique region in individuals with recent and persistent parvovirus B19 infection.
Lindner J; Barabas S; Saar K; Altmann D; Pfister A; Fleck M; Deml L; Modrow S
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):356-61. PubMed ID: 16316401
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?
Mitchell LA
J Med Virol; 2002 Jun; 67(2):267-74. PubMed ID: 11992589
[TBL] [Abstract][Full Text] [Related]
14. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19 infection in Behçet's disease.
Kiraz S; Ertenli I; Benekli M; Calgüneri M
Clin Exp Rheumatol; 1996; 14(1):71-3. PubMed ID: 8697661
[TBL] [Abstract][Full Text] [Related]
16. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review.
Nigro G; Bastianon V; Colloridi V; Ventriglia F; Gallo P; D'Amati G; Koch WC; Adler SP
Clin Infect Dis; 2000 Jul; 31(1):65-9. PubMed ID: 10913398
[TBL] [Abstract][Full Text] [Related]
17. Aberrant cellular immune responses in humans infected persistently with parvovirus B19.
Isa A; Norbeck O; Hirbod T; Lundqvist A; Kasprowicz V; Bowness P; Klenerman P; Broliden K; Tolfvenstam T
J Med Virol; 2006 Jan; 78(1):129-33. PubMed ID: 16299714
[TBL] [Abstract][Full Text] [Related]
18. A study on the association between parvovirus B19 infection, serum tumour necrosis factor and C-reactive protein levels among Nigerian patients with sickle cell anaemia.
Iwalokun BA; Iwalokun SO; Hodonu SO; Aina OA; Omilabu S
Singapore Med J; 2012 Nov; 53(11):726-31. PubMed ID: 23192499
[TBL] [Abstract][Full Text] [Related]
19. Molecular Study of Parvovirus B19 Infection in Children with Acute Myeloid Leukemia.
Tharwat Abou El-Khier N; Darwish A; El Sayed Zaki M
Asian Pac J Cancer Prev; 2018 Feb; 19(2):337-342. PubMed ID: 29479965
[TBL] [Abstract][Full Text] [Related]
20. Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia.
Kerr JR; Barah F; Cunniffe VS; Smith J; Vallely PJ; Will AM; Wynn RF; Stevens RF; Taylor GM; Cleator GM; Eden OB
J Clin Pathol; 2003 Nov; 56(11):873-5. PubMed ID: 14600138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
